Matrine inhibits the expression of adhesion molecules in activated vascular smooth muscle cells. 2016

Jun Liu, and Lihua Zhang, and Yingang Ren, and Yanli Gao, and Li Kang, and Shaoping Lu
Department of Geriatrics, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi 710038, P.R. China.

Atherosclerosis is a chronic inflammatory disease associated with increased expression of adhesion molecules in vascular smooth muscle cells (VSMCs). Matrine is a main active ingredient of Sophora flavescens roots, which are used to treat inflammatory diseases. However, the effects of matrine on the expression of adhesion molecules in VSMCs have largely remained elusive. Therefore, the present study investigated the effects of matrine on the expression of adhesion molecules in tumor necrosis factor (TNF)‑α‑stimulated human aortic smooth muscle cells (HASMCs). The results showed that matrine inhibited the expression of vascular cell adhesion molecule‑1 (VCAM‑1) and intercellular adhesion molecule‑1 (ICAM‑1) in TNF‑α‑stimulated HASMCs. Matrine markedly inhibited the TNF‑α‑induced expression of nuclear factor (NF)‑κB p65 and prevented the TNF‑α‑caused degradation of inhibitor of NF‑κB; it also inhibited TNF‑α‑induced activation of mitogen‑activated protein kinases (MAPKs). Furthermore, matrine inhibited the production of intracellular reactive oxygen species (ROS) in TNF‑α‑stimulated HASMCs. In conclusion, the results of the present study demonstrated that matrine inhibited the expression of VCAM‑1 and ICAM‑1 in TNF‑α‑stimulated HASMCs via the suppression of ROS production as well as NF‑κB and MAPK pathway activation. Therefore, matrine may have a potential therapeutic use for preventing the advancement of atherosclerotic lesions.

UI MeSH Term Description Entries
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011807 Quinolizines
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072000 NF-KappaB Inhibitor alpha An I-kappa B protein that inhibits the activity of dimeric NF-KAPPA B P50-REL complexes, sequesters transcription factor NF-kappaB as an inactive complex in the cytoplasm; and prevents NF-kappaB nuclear translocation and DNA binding. I Kappa B-alpha Protein,IKappaB-alpha,IKappaBalpha,Major Histocompatibility Complex Enhancer-Binding Protein MAD3,p40 Protein (IKappaB-alpha),I Kappa B alpha Protein,IKappaB alpha,Inhibitor alpha, NF-KappaB,Major Histocompatibility Complex Enhancer Binding Protein MAD3,NF KappaB Inhibitor alpha,alpha, NF-KappaB Inhibitor
D000093842 Matrines Tetracyclic bis-quinolizidine alkaloids found in the family LEGUMINOSAE, mainly in the genus SOPHORA. Matrine,Matrine Alkaloids,Matrine, (5beta)-Isomer,Matrine-type Alkaloids,Sophoridine,Matrine type Alkaloids
D000470 Alkaloids Organic nitrogenous bases. Many alkaloids of medical importance occur in the animal and vegetable kingdoms, and some have been synthesized. (Grant & Hackh's Chemical Dictionary, 5th ed) Alkaloid,Plant Alkaloid,Plant Alkaloids,Alkaloid, Plant,Alkaloids, Plant
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

Jun Liu, and Lihua Zhang, and Yingang Ren, and Yanli Gao, and Li Kang, and Shaoping Lu
February 2012, International immunopharmacology,
Jun Liu, and Lihua Zhang, and Yingang Ren, and Yanli Gao, and Li Kang, and Shaoping Lu
January 2019, International immunopharmacology,
Jun Liu, and Lihua Zhang, and Yingang Ren, and Yanli Gao, and Li Kang, and Shaoping Lu
February 1999, Cardiovascular research,
Jun Liu, and Lihua Zhang, and Yingang Ren, and Yanli Gao, and Li Kang, and Shaoping Lu
November 2017, Molecular medicine reports,
Jun Liu, and Lihua Zhang, and Yingang Ren, and Yanli Gao, and Li Kang, and Shaoping Lu
May 1995, Atherosclerosis,
Jun Liu, and Lihua Zhang, and Yingang Ren, and Yanli Gao, and Li Kang, and Shaoping Lu
September 2016, Biochemical pharmacology,
Jun Liu, and Lihua Zhang, and Yingang Ren, and Yanli Gao, and Li Kang, and Shaoping Lu
August 2006, Journal of leukocyte biology,
Jun Liu, and Lihua Zhang, and Yingang Ren, and Yanli Gao, and Li Kang, and Shaoping Lu
May 1999, The American journal of physiology,
Jun Liu, and Lihua Zhang, and Yingang Ren, and Yanli Gao, and Li Kang, and Shaoping Lu
October 2010, Acta pharmacologica Sinica,
Jun Liu, and Lihua Zhang, and Yingang Ren, and Yanli Gao, and Li Kang, and Shaoping Lu
July 2012, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!